Pular para o conteúdo
Merck

Sydnone SYD-1 affects the metabolic functions of isolated rat hepatocytes.

Chemico-biological interactions (2014-05-20)
Anna Paula Brandt, Amanda do Rocio Andrade Pires, Maria Eliane Merlin Rocha, Guilhermina Rodrigues Noleto, Alexandra Acco, Carlos Eduardo Alves de Souza, Aurea Echevarria, André Vinícius dos Santos Canuto, Sílvia Maria Suter Correia Cadena
RESUMO

Previously, we demonstrated that sydnone SYD-1 (3-[4-chloro-3-nitrophenyl]-1,2,3-oxadiazolium-5-olate) impairs the mitochondrial functions linked to energy provision and suggested that this effect could be associated with its antitumor activity. Herein, we evaluated the effects of SYD-1 (25 and 50 μM) on rat hepatocytes to determine its cytotoxicity on non-tumor cells. SYD-1 (25 and 50 μM) did not affect the viability of hepatocytes in suspension after 1-40 min of incubation. However, the viability of the cultured hepatocytes was decreased by ∼66% as a consequence of treatment with SYD-1 (50 μM) for 18 h. Under the same conditions, SYD-1 promoted an increase in the release of LDH by ∼19%. The morphological changes in the cultured cells treated with SYD-1 (50 μM) were suggestive of cell distress, which was demonstrated by the presence of rounded hepatocytes, cell fragments and monolayer impairment. Furthermore, fluorescence microscopy showed an increase in the annexin label after treatment with SYD-1 (50 μM), suggesting that apoptosis had been induced in these cells. SYD-1 did not affect the states of respiration in the suspended hepatocytes, but the pyruvate levels were decreased by ∼36%, whereas the lactate levels were increased by ∼22% (for the 50 μM treatment). The basal and uncoupled states of respiration of the cultured hepatocytes were inhibited by ∼79% and ∼51%, respectively, by SYD-1 (50 μM). In these cells, SYD-1 (50 μM) increased the pyruvate and lactate levels by ∼84% and ∼16%, respectively. These results show that SYD-1 affects important metabolic functions related to energy provision in hepatocytes and that this effect was more pronounced on cells in culture than those in suspension.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
HEPES, ≥99.5% (titration)
Sigma-Aldrich
HEPES, BioPerformance Certified, ≥99.5% (titration), suitable for cell culture
Sigma-Aldrich
Dexametasona, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Carbonilcianeto 4-(trifluorometoxi)fenil-hidrazona, ≥98% (TLC), powder
Sigma-Aldrich
Rotenone, ≥95%
Sigma-Aldrich
Pyruvic acid, 98%
Sigma-Aldrich
HEPES, BioUltra, for molecular biology, ≥99.5% (T)
Sigma-Aldrich
Dexametasona, ≥98% (HPLC), powder
Sigma-Aldrich
HEPES, 1 M in H2O
Sigma-Aldrich
Lactic acid, meets USP testing specifications
SAFC
HEPES
Sigma-Aldrich
Lactic acid, 85%, FCC
Sigma-Aldrich
Lactic acid, natural, ≥85%
Sigma-Aldrich
HEPES, BioXtra, suitable for mouse embryo cell culture, ≥99.5% (titration)
SAFC
HEPES
Sigma-Aldrich
Dexametasona, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
DL-Lactic acid, 85 % (w/w), syrup
Sigma-Aldrich
HEPES, BioXtra, pH 5.0-6.5 (1 M in H2O), ≥99.5% (titration)
Sigma-Aldrich
Pyruvic acid, ≥97%, FG
Sigma-Aldrich
Pyruvic acid, 95%
Sigma-Aldrich
Lactic acid solution, ACS reagent, ≥85%
Sigma-Aldrich
DL-Lactic acid, ~90% (T)
Supelco
Dexametasona, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Lactic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Pyruvic acid, natural, ≥95%, FG
Sigma-Aldrich
HEPES, anhydrous, free-flowing, Redi-Dri, ≥99.5%
Sigma-Aldrich
Dexametasona, meets USP testing specifications
Supelco
HEPES, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Rotenone, PESTANAL®, analytical standard
Sigma-Aldrich
Dexametasona, tested according to Ph. Eur.